Observational studyThe Journal of dermatology2024

Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.

Yayoi Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.